Trade Report: Today: Brokerages Set Dechra Pharmaceuticals plc (DPH) Price Target at $1,296.43

Today: Brokerages Set Dechra Pharmaceuticals plc (DPH) Price Target at $1,296.43

Shares of Dechra Pharmaceuticals plc (LON:DPH) have been assigned an average rating of “Buy” from the eight research firms that are covering the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is GBX 1,296.43 ($16.04).

A number of equities research analysts recently weighed in on the company. FinnCap restated an “under review” rating on shares of Dechra Pharmaceuticals plc in a research report on Tuesday, August 30th. Jefferies Group boosted their price objective on Dechra Pharmaceuticals plc from GBX 1,229 ($15.21) to GBX 1,295 ($16.03) and gave the stock a ” hold” rating in a research report on Wednesday, September 7th. Numis Securities Ltd restated an “add” rating and set a GBX 1,285 ($15.90) price objective on shares of Dechra Pharmaceuticals plc in a research report on Friday, June 24th. N+1 Singer restated a “buy” rating and set a GBX 1,350 ($16.71) price objective on shares of Dechra Pharmaceuticals plc in a research report on Friday, September 16th. Finally, Panmure Gordon restated a “buy” rating and set a GBX 1,140 ($14.11) price objective on shares of Dechra Pharmaceuticals plc in a research report on Sunday, September 11th.

Shares of Dechra Pharmaceuticals plc (LON:DPH) opened at 1355.00 on Friday. The company’s market capitalization is GBX 1.26 billion. Dechra Pharmaceuticals plc has a one year low of GBX 811.00 and a one year high of GBX 1,462.00. The firm has a 50 day moving average price of GBX 1,362.76 and a 200 day moving average price of GBX 1,232.72.

Related posts

Leave a Comment